Cargando…
Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570227/ https://www.ncbi.nlm.nih.gov/pubmed/37597128 http://dx.doi.org/10.1007/s40257-023-00813-4 |
_version_ | 1785119716568727552 |
---|---|
author | Chiricozzi, Andrea Ortoncelli, Michela Schena, Donatella Gori, Niccolò Ferrucci, Silvia Mariel Babino, Graziella Napolitano, Maddalena Fargnoli, Maria Concetta Stingeni, Luca Rossi, Mariateresa Romanelli, Marco Balestri, Riccardo Pellegrino, Michele Parodi, Aurora Bertoldi, Alberto Maria Palazzo, Giovanni Antonelli, Flaminia Pitino, Annalisa Tripepi, Giovanni Fabbrocini, Gabriella Balato, Anna Marzano, Angelo Valerio Girolomoni, Giampiero Ribero, Simone Peris, Ketty |
author_facet | Chiricozzi, Andrea Ortoncelli, Michela Schena, Donatella Gori, Niccolò Ferrucci, Silvia Mariel Babino, Graziella Napolitano, Maddalena Fargnoli, Maria Concetta Stingeni, Luca Rossi, Mariateresa Romanelli, Marco Balestri, Riccardo Pellegrino, Michele Parodi, Aurora Bertoldi, Alberto Maria Palazzo, Giovanni Antonelli, Flaminia Pitino, Annalisa Tripepi, Giovanni Fabbrocini, Gabriella Balato, Anna Marzano, Angelo Valerio Girolomoni, Giampiero Ribero, Simone Peris, Ketty |
author_sort | Chiricozzi, Andrea |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10570227 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-105702272023-10-14 Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation Chiricozzi, Andrea Ortoncelli, Michela Schena, Donatella Gori, Niccolò Ferrucci, Silvia Mariel Babino, Graziella Napolitano, Maddalena Fargnoli, Maria Concetta Stingeni, Luca Rossi, Mariateresa Romanelli, Marco Balestri, Riccardo Pellegrino, Michele Parodi, Aurora Bertoldi, Alberto Maria Palazzo, Giovanni Antonelli, Flaminia Pitino, Annalisa Tripepi, Giovanni Fabbrocini, Gabriella Balato, Anna Marzano, Angelo Valerio Girolomoni, Giampiero Ribero, Simone Peris, Ketty Am J Clin Dermatol Correction Springer International Publishing 2023-08-19 2023 /pmc/articles/PMC10570227/ /pubmed/37597128 http://dx.doi.org/10.1007/s40257-023-00813-4 Text en © Springer Nature Switzerland AG 2023 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Correction Chiricozzi, Andrea Ortoncelli, Michela Schena, Donatella Gori, Niccolò Ferrucci, Silvia Mariel Babino, Graziella Napolitano, Maddalena Fargnoli, Maria Concetta Stingeni, Luca Rossi, Mariateresa Romanelli, Marco Balestri, Riccardo Pellegrino, Michele Parodi, Aurora Bertoldi, Alberto Maria Palazzo, Giovanni Antonelli, Flaminia Pitino, Annalisa Tripepi, Giovanni Fabbrocini, Gabriella Balato, Anna Marzano, Angelo Valerio Girolomoni, Giampiero Ribero, Simone Peris, Ketty Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation |
title | Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation |
title_full | Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation |
title_fullStr | Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation |
title_full_unstemmed | Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation |
title_short | Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation |
title_sort | correction to: long-term effectiveness and safety of upadacitinib for atopic dermatitis in a real-world setting: an interim analysis through 48 weeks of observation |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570227/ https://www.ncbi.nlm.nih.gov/pubmed/37597128 http://dx.doi.org/10.1007/s40257-023-00813-4 |
work_keys_str_mv | AT chiricozziandrea correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation AT ortoncellimichela correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation AT schenadonatella correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation AT goriniccolo correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation AT ferruccisilviamariel correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation AT babinograziella correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation AT napolitanomaddalena correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation AT fargnolimariaconcetta correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation AT stingeniluca correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation AT rossimariateresa correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation AT romanellimarco correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation AT balestririccardo correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation AT pellegrinomichele correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation AT parodiaurora correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation AT bertoldialbertomaria correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation AT palazzogiovanni correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation AT antonelliflaminia correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation AT pitinoannalisa correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation AT tripepigiovanni correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation AT fabbrocinigabriella correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation AT balatoanna correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation AT marzanoangelovalerio correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation AT girolomonigiampiero correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation AT riberosimone correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation AT perisketty correctiontolongtermeffectivenessandsafetyofupadacitinibforatopicdermatitisinarealworldsettinganinterimanalysisthrough48weeksofobservation |